stefano | Clinical Neuroscience | Innovative Research Award

Dr. Stefano | Clinical Neuroscience | Innovative Research Award

Dr. Stefano, Ospedale Santa Chiara Trento, Italy.

Dr. Stefano Branzoli is a highly accomplished cardiac surgeon with decades of experience spanning Italy, Belgium, and the United States. After completing his medical studies at the University of Pavia, he advanced through elite international training, including a fellowship at the Mayo Clinic. His career has focused on surgical innovation in cardiac electrophysiology, with particular emphasis on thoracoscopic ablation for atrial fibrillation, stroke prevention, and ventricular arrhythmias. Through his roles at Santa Chiara Hospital and Universitair Ziekenhuis Brussel, he has contributed extensively to both clinical practice and academic research.

Profile

Orcid

🧬 Early Academic Pursuits


Dr. Stefano Branzoli began his journey into medicine at the prestigious University of Pavia, where he earned his degree in Medicine and Surgery between 1992 and 1998. Driven by a deep curiosity for cardiovascular science, he embarked on rigorous postgraduate training, marking the start of an extraordinary career in cardiac surgery. His academic excellence soon opened international doors, including a coveted fellowship at the Mayo Clinic in Rochester, Minnesota.

🏥 Professional Endeavors


From 1999 to 2004, Dr. Branzoli honed his clinical expertise as a resident in cardiac surgery at the University of Pavia. He became board-certified after completing the USMLE in 2000, equipping him with transatlantic qualifications. Since 2005, he has served in the Cardiac Surgery Unit at Santa Chiara Hospital in Trento, Italy, while also expanding his reach as a specialist at the Universitair Ziekenhuis Brussel in Belgium since 2019. These dual roles reflect his commitment to advancing surgical standards across borders.Contributions to Cardiac ElectrophysiologyThroughout his career, Dr. Branzoli has been instrumental in the development and refinement of procedures targeting arrhythmias. His clinical and research contributions in thoracoscopic ablation for atrial fibrillation, stroke prevention, and epicardial ablation for ventricular arrhythmias have positioned him as a leading voice in electrophysiological cardiac surgery. He has been particularly focused on minimally invasive techniques that reduce patient recovery time while enhancing procedural efficacy.

🔬 Research Focus and Innovation


Dr. Branzoli’s research portfolio reflects his dedication to solving complex cardiovascular challenges. He has led and contributed to significant projects centered on atrial fibrillation, stroke prevention strategies, and novel ablative techniques. His work bridges the gap between traditional surgical approaches and cutting-edge electrophysiological interventions, helping shape the future of cardiac care through both clinical practice and investigative science.

🏅 Accolades and Recognition


Though modest in demeanor, Dr. Branzoli’s accomplishments have earned him respect in academic and clinical circles alike. His training at the Mayo Clinic—a global epicenter for cardiac research—along with his dual appointments in Italy and Belgium, speak volumes of his international reputation. His involvement in advanced cardiac rhythm management has earned recognition from peers and institutions aiming to elevate surgical excellence.

🌍 Impact and Influence


Beyond the operating theater, Dr. Branzoli’s influence is reflected in the widespread adoption of thoracoscopic ablation techniques and his mentorship of upcoming cardiac surgeons in Europe. By integrating cross-border expertise, he has played a vital role in aligning surgical standards and promoting collaborative research between institutions in Italy, Belgium, and beyond.

đź”® Legacy and Future Contributions


As medicine evolves toward personalized, minimally invasive therapies, Dr. Branzoli stands at the forefront of surgical innovation. His work continues to inspire new pathways in arrhythmia management and stroke prevention. With a career spanning continents and a mind open to continual learning, his legacy is defined not only by lives saved but also by knowledge passed on to future generations of cardiovascular specialists.

Publication

  • Title: Patients with Gastrointestinal Bleeding and Atrial Fibrillation: Potential Ideal Target for Epicardial Appendage Occlusion
    Authors: Stefano Branzoli, Massimiliano Marini, Domenico Catanzariti, Cecilia Pravadelli, Luigi Pannone, Giovanni D’Onghia, Mauro Fantinel, Fabrizio Guarracini, Gaia Franceschini, Mirco Zadro et al.
    Year: 2025

 

  • Title: Heart Team for Left Appendage Occlusion without the Use of Antithrombotic Therapy: The Epicardial Perspective
    Authors: Stefano Branzoli, Fabrizio Guarracini, Massimiliano Marini, Giovanni D’Onghia, Domenico Catanzariti, Elettra Merola, Luciano Annicchiarico, Giulia Casagranda, Chiara Stegagno, Mauro Fantinel et al.
    Year: 2022

 

âś… Conclusion


Dr. Branzoli’s enduring commitment to advancing cardiac surgery has had a meaningful impact on patient care, research, and education. With a legacy rooted in innovation, cross-cultural collaboration, and a passion for arrhythmia management, he continues to influence the evolving field of cardiovascular medicine. His work serves as a bridge between traditional surgical methods and modern electrophysiological therapies—ensuring that the future of heart care is not only safer and more effective but also profoundly human-centered.

Shumao Xu | Neurotechnology | Best Researcher Award

Assoc. Prof. Dr. Shumao Xu | Neurotechnology | Best Researcher Award

Assoc. Prof. Dr.  Shumao Xu, Fudan University, China.

Shumao Xu’s career embodies a fusion of material science, biomedical engineering, and neurotechnology, leading to remarkable advancements in neural interfaces and brain-computer interaction. His extensive research, industry collaborations, and prestigious funding awards highlight his influence in the field. With over 60 high-impact publications and thousands of citations, his work has significantly contributed to neuroengineering, setting the foundation for future innovations.

Profile

Orcid

✨ Early Academic Pursuits

Shumao Xu’s journey in academia began with a passion for innovation and exploration in neural interfaces and biomedical engineering. He pursued his Ph.D. at Shanghai Jiao Tong University (SJTU), where he laid the foundation for his research in neural engineering. His early academic years were marked by rigorous studies in material science, bioelectronics, and neurotechnology, setting the stage for his groundbreaking work in neural interfaces. His commitment to excellence led him to postdoctoral training at the prestigious Max Planck Institute for Solid-State Research as an Alexander von Humboldt scholar, followed by further research at Pennsylvania State University and UCLA.

👨‍🎓 Professional Endeavors

Currently an Associate Professor and Principal Investigator at Fudan University’s Institute of Science and Technology for Brain-Inspired Intelligence (ISTBI), Shumao Xu is recognized as a National Overseas Young Talent (2024). His professional trajectory has been defined by his commitment to advancing brain-computer interfaces and neurotechnology. Securing funding from prestigious organizations such as the National Natural Science Foundation of China (NSFC), China Postdoctoral Science Foundation (Innovative Program), and the Shanghai Super Postdoctoral Program, he has spearheaded research that pushes the boundaries of neural engineering.

đź§  Contributions and Research Focus

Shumao Xu has dedicated his research to developing state-of-the-art neural interfaces that revolutionize neurostimulation and brain-computer interactions. His pioneering work includes implantable neural electrodes, non-invasive deep brain stimulation, calcium imaging, and non-genetic optoelectronic neural interfaces. His research extends to the development of soft magnetoelastic energy harvesters, injectable fluorescent neural probes, and triboelectric neurostimulators for self-powered neural systems. His work is crucial in creating biocompatible and energy-efficient neurotechnologies that have the potential to treat neurodegenerative diseases and enhance brain function.

🏆 Accolades and Recognition

With over 60 high-impact publications in renowned journals such as Advanced Materials, Nature Communications, Nano Letters, Matter, and Chem, Shumao Xu has established himself as a leading researcher in neurotechnology. His impressive h-index of 28 and more than 3,300 citations stand as a testament to the significance of his contributions. He has been honored with funding from the NSFC Oversea Young Talent program for his work on injectable fluorescent neural probes and received the Humboldt Foundation’s support for optoelectronic neural modulation. His research has gained international recognition, earning him industry collaborations and consultancy projects.

⚛️ Impact and Influence

Beyond academia, Shumao Xu’s work has practical applications in the medical and technological sectors. His collaborations with leading industry giants, such as Showa Denko and Teijin in Tokyo, Japan, have translated his academic innovations into real-world applications. His research in neural interfaces and brain-computer technologies has the potential to revolutionize treatments for neurological disorders, offering new hope to patients with neurodegenerative diseases. His advancements in self-powered neural stimulation systems have paved the way for sustainable and long-lasting neurotechnologies.

đź’ˇ Legacy and Future Contributions

As a visionary in neuroengineering, Shumao Xu continues to shape the future of brain-computer interfaces and neural modulation. His work is not only contributing to academic advancements but also influencing the next generation of researchers and engineers in neurotechnology. His ongoing research projects, including biocompatible neural electrodes and optoelectronic neural modulation, promise to drive innovation in the field. Through his relentless pursuit of scientific breakthroughs, he aims to bridge the gap between neuroscience and technology, ultimately transforming the landscape of brain-computer interaction and neurotherapy.

Publication

  • Artificial intelligence assisted nanogenerator applications

    • Authors: Shumao Xu, Farid Manshaii, Xiao Xiao, Jun Chen

    • Year: 2025

 

  • Advances in 2D materials for wearable biomonitoring

    • Authors: Songyue Chen, Shumao Xu, Xiujun Fan, Xiao Xiao, Zhaoqi Duan, Xun Zhao, Guorui Chen, Yihao Zhou, Jun Chen

    • Year: 2025

 

  • A comprehensive review on the mechanism of contact electrification

    • Authors: J Tian, Y He, F Li, W Peng, Y He, Shumao Xu, F Manshaii, X Xiao, Jun Chen

    • Year: 2025

 

  • Advances in Brain Computer Interface for Amyotrophic Lateral Sclerosis Communication

    • Authors: Yuchun Wang, Yurui Tang, Qianfeng Wang, Minyan Ge, Jinling Wang, Xinyi Cui, Nianhong Wang, Zhijun Bao, Shugeng Chen, Jing Wang et al.

    • Year: 2025

 

  • Tailored Terminal Groups in MXenes for Fast-Charging and Safe Energy Storage

    • Authors: Shumao Xu, Minyan Ge, Weiqiang Zhang, Yuchun Wang, Yurui Tang

    • Year: 2025

 

  • Heart-brain connection: How can heartbeats shape our minds?

    • Authors: Xu Shumao, Scott Kamryn, Manshaii Farid, Chen Jun

    • Year: 2024

  • Injectable Fluorescent Neural Interfaces for Cell-Specific Stimulating and Imaging

    • Authors: Xu Shumao, Xiao Xiao, Manshaii Farid, Chen Jun

    • Year: 2024

 

  • Multiphasic interfaces enabled aero-elastic capacitive pressure sensors

    • Authors: Xu Shumao, Manshaii Farid, Chen Jun

    • Year: 2024

 

  • Reversible metal-ligand coordination for photocontrolled metallopolymer adhesives

    • Authors: Xu Shumao, Manshaii Farid, Chen Guorui, Chen Jun

    • Year: 2024

 

  • Self-Thermal Management in Filtered Selenium-Terminated MXene Films for Flexible Safe Batteries

    • Authors: Pang Xin, Lee Hyunjin, Rong Jingzhi, Zhu Qiaoyu, Xu Shumao

    • Year: 2024

 

🌟 Conclusion

Shumao Xu’s pioneering research and dedication to neural engineering continue to push the boundaries of brain-inspired intelligence and medical advancements. His visionary contributions have paved the way for next-generation neurotechnologies that hold the potential to transform neurological treatments and human-computer interactions. As he continues his groundbreaking research, his legacy will inspire future scientists and engineers, driving forward the possibilities of neurotechnology for years to come.

Nawal Al-Subaie | Clinical Neuroscience | Best Researcher Award

Assist Prof Dr. Nawal Al-Subaie | Clinical Neuroscience | Best Researcher Award

Assist Prof Dr. Nawal Al-Subaie,  Princess Noura University, Saudi Arabia

Nawal Al Subaie is a dedicated Clinical Pharmacist with extensive experience in clinical and academic roles at esteemed institutions, including Prince Sultan Military Medical City (PSMMC) and Princess Noura University (PNU). She holds a PhD in Clinical Pharmacy from DMU, UK, and a Master’s in International Practice and Policy from UCL, London. With a career spanning leadership, clinical care, and education, she has made significant contributions to pharmacy practice, quality control, and chronic disease management. Her commitment to continuous learning is reflected in numerous specialized courses and symposiums, along with frequent contributions to global conferences.

 

profile

scholor

🎓 Educational Background

PhD in Clinical Pharmacy,DMU Leicester, United Kingdom.MSc in Clinical Pharmacy (International Practice and Policy)
,UCL School of Pharmacy, London, United Kingdom.Bachelor’s Degree in Hospital Pharmacy,King Saud University, Riyadh, Saudi Arabia.

đź’Ľ Working Experience

Deputy in Charge of Pharmacy Division.Family and Community Medicine.Lead Pharmacist. Wazarat Health Centre (WHC).Clinical Pharmacist,Chronic Disease Clinic, WHC.Clinical Instructor / Trainer,Continuous education for pharmacy students at King Saud University, Princess Noura University, Northern Border University.Quality Control Representative Pharmacy, WHC.Part-time Lecturer,Clinical Ocular Pharmacology, King Saud University.JCI Accreditation Awardee,Primary Care Team.In-Charge of Clinical Pharmacist Ambulatory Care Clinics, PSMMC, 2020–2022.Assistant Professor,Princess Noura University (PNU), May 2022 – Present.

🏫 Training Courses / Symposiums

2015 – 2019: PhD Student (Diabetes and Exercise)Pharmacy School, DMU, UK.2014: TOT Course Leicester, UK.2016: Phlebotomy Course Nottingham, UK.2016: First Aid CourseLeicester, UK.2022: ASHP Diabetes Management Certificate Course January – December 2022.

🌍 Conferences Attended & Contributions

2024: Attended the 4th Saudi Society of Clinical Pharmacist Annual International Conference (September).2024: Presented Poster at Dubai International Pharmaceuticals and Technologies Conference.2023: Oral Presentation at Neurology Conference, Dubai (March).2023: Judge, Pharmacy Research Day, PNU Research Center (May).2022: Attended First Saudi Society of Clinical Pharmacist Annual International Conference (September)(and many more from 2000 to 2024)

🤲 Voluntary Work

University orientation for new students, DMU. Diabetes Awareness Day, in collaboration with Diabetes UK. Trained students at DMU on ELISA and Randox machine for blood sample analysis. Assisted pharmacy students with projects and dissertations, DMU

🏅 Professional Memberships

Saudi Commission for Health Specialties (ID: 09-R-P-0295492)

📚 Publications

  1. Statins Use in Alzheimer Disease: Bane or Boon from Frantic Search and Narrative Review
    Authors: N. Alsubaie, H.M. Al-Kuraishy, A.I. Al-Gareeb, B. Alharbi, M. De Waard, …
    Year: 2022

 

  1. Discussing Pathologic Mechanisms of Diabetic Retinopathy & Therapeutic Potentials of Curcumin and β-glucogallin in the Management of Diabetic Retinopathy
    Authors: M. Rohilla, S. Bansal, A. Garg, S. Dhiman, S. Dhankhar, M. Saini, S. Chauhan, …
    Year: 2023

 

  1. The Potential Therapeutic Effect of Metformin in Type 2 Diabetic Patients with Severe COVID-19
    Authors: H.M. Al-Kuraishy, A.I. Al-Gareeb, A.A. El Kholy, E. El-Khateeb, A. Alexiou, …
    Year: 2023

 

  1. The Effects of a Combined Exercise Programme Aerobic and Resistance on Blood Glucose, Incretin, Metabolic and Inflammatory Mediators that Could Control the Diabetes and Improve …
    Author: N. Alsubaie
    Year: 2019

 

  1. Corrigendum to “Discussing Pathologic Mechanisms of Diabetic Retinopathy & Therapeutic Potentials of Curcumin and β-glucogallin in the Management of Diabetic Retinopathy”
    Authors: M. Rohilla, S. Bansal, A. Garg, S. Dhiman, S. Dhankhar, M. Saini, S. Chauhan, …
    Year: 2024

 

  1. Impact of Clinical Pharmacist Diabetes Clinic on the Improvement of Health Outcomes in Type 2 Diabetes Subjects
    Authors: N. AlSubaie, M. Alsallal, S. AlTwaijri, A. AlOtaibi, B. AlHarbi, M. AlEissa, …
    Year: 2022

 

  1. The Effects of a Combined Aerobic and Resistance Exercise Programme on Insulin Resistance Among Prediabetes Subjects
    Authors: B. Alharbi, N. Alsubaie, T.S. Sahota, M.J. Taylor
    Year: 2019

 

  1. The Effects of a Combined Exercise Programme (Aerobic and Resistance) on Blood Glucose and Incretin Hormone That Could Control the Diabetes in Type 2 Diabetes
    Authors: N. Alsubaie, B. Alharbi, T.S. Sahota, M.J. Taylor
    Year: 2019

 

  1. The Effects of a Combined Exercise Programme (Aerobic and Resistance) on Blood Glucose, and Incretin Hormone That Could Control the Diabetes in Type 2 Diabetes
    Authors: B.M. Alharbi, N.S. Alsubaie, T.S. Sahota, M.J. Taylor
    Year: 2019

 

  1. The Impact of Moderate Combination Exercise on HbA1c, IL-6, and TNF in Type 2 Diabetic and Non-diabetic Subjects: An Interventional Non-randomized Clinical Trial
    Authors: B. Alharbi, N. Alsubaie, T.S. Sahota, M.J. Taylor
    Year: 2019

 

 Conclusion

Dr. Al Subaie’s career showcases a deep commitment to enhancing patient care, advancing pharmaceutical education, and contributing to international health discussions. Her background in both hands-on clinical care and academic research equips her with a well-rounded perspective, making her a valuable asset in clinical and educational settings alike. She continues to make strides in diabetes management, chronic disease care, and pharmacy education, with her work recognized through multiple presentations, awards, and professional memberships.